Crystagen
Research profile · How we handle evidence
Crystagen is a short, sequence-defined peptide complex that shows up in early, research-oriented discussions around lens health and cataract-related hypotheses. Human safety and effectiveness data are not well established, so treat it as experimental information—not a substitute for cataract care.
Evidence Score
Preclinical signal
Category
Therapeutic area
Standard Dose
Daily
Half-life
Plasma elimination
Route
Subcutaneous or Eye Drops
Safety Tier
Limited data
Overview
Crystagen is discussed as an eye-lens–targeted peptide complex. Explanations typically focus on lens-cell support and related molecular signaling ideas. Some people use it as a topical/eye-drop style regimen, but for most users this is still research territory. If you have symptoms or worsening cataracts, don’t rely on peptides instead of medical evaluation.
Mechanism of Action
Crystagen is discussed as an eye-lens–targeted peptide complex. Explanations typically focus on lens-cell support and related molecular signaling ideas. Some people use it as a topical/eye-drop style regimen, but for most users this is still research territory. If you have symptoms or worsening cataracts, don’t rely on peptides instead of medical evaluation.
pH & Mixing
Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.
A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.
Benefits
- Eye health support
- Lens protection
- Cataract prevention
- Vision support
Side Effects
- Possible eye irritation if used topically (redness, burning, dryness)
- Discomfort can happen with many experimental eye-drop regimens
Contraindications
- Pregnant or breastfeeding women
- Current eye infections or active eye inflammation
Structure & Sequence
Verified structure
Crystagen
Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.
- Amino Acid Sequence
- Glu-Asp-Pro (EDP)
- Molecular Weight
- 359.34 Da
- Chemical Formula
- C14H21N3O8
- CAS Number
- N/A
- Reconstituted pH
- 3.8
Stack & Route Context
Stacks with
- Thymosin Alpha-1
- Livagen
Administration
Subcutaneous or Eye Drops
Research Status
Research peptide for eye health
Approval Status
Preclinical
Sports Legal
Permitted
References
No references listed.
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.